Introduction
Mupirocin is an antibiotic used topically for the treatment of staphylococcal and streptococcal skin infections and for the eradication of carriage of Staphylococcus aurezts, including strains resistant to methicillin (MRSA). High-level, transferable resistance to mupirocin (MIC 3 512 mg/L) [I] was first reported among clinical isolates of 5'. azirezis from a London hospital [2] and abrogates the effective clinical use of the agent. This form of resistance is encountered increasingly in the UK, particularly in the south-east of England, and is exhibited by both methicillin-sensitive and -resistant S. aureus. In particular, its association with various epidemic strains of MRSA (EMRSA) may cause serious infection control problems [3].
High-level mupirocin resistance results from the acquisition of new DNA which encodes production of a mupirocin-resistant isoleucyl tRNA synthetase [I] . In the presence of mupirocin, this enzyme takes over the function of the sensitive chromosomal enzyme. The resistance gene has been cloned [4] , sequenced [ 5 ] and probes have been used to investigate its distribution. It has been designated variously ileS [ 5 ] , ileS-2 [6] or mzipA [7] . Hereafter, it will be referred to as mupA. This gene is carried on diverse plasmids, although plasmids in epidemiologically related isolates may appear similar [S] . However, despite this diversity of plasmids, the mupA gene is located on an c. 4-kb EcoRI DNA fragment in all but three high-level mupirocin-resistant isolates of S. aurezis and coagulase-negative staphylococci examined previously [9-121. 
Materials and methods

Bacterial isolates
Eighty-five clinical isolates of S. aureus with high-level resistance to mupirocin (MIC 3 512 mg/L) were included in this study. In the initial investigations, 15 isolates from different centres were chosen to represent various strains causing current problems in UK hospitals (Table 1) . These were five epidemiologically distinct isolates of EMRSA-16 (including the first high-level mupirocin-resistant isolate of this strain from 1993), two isolates of EMRSA-3, two other non-epidemic MRSA strains (OMRSA) and six isolates of a mecA-negative strain with intermediate methicillin resistance (MIC 4-8 mg/L, IMRSA) [3] . In addition, isolates 'STH 1' and 'Bristol 3', both of which had been shown previously to hybridise with a mupirocin resistance probe [lo, 113, were included as controls for hybridisation and PCR studies. Subsequently, studies were extended to include 16 isolates of EMRSA-16 referred from different UK hospitals during 1995 and 52 S. aureus isolates referred from a single UK centre since 1991. Isolates from this latter centre represented numerous phage types and were mainly methicillin-sensitive isolates from patients prescribed mupirocin in the community and referred by their general practitioners to outpatient clinics.
Transfer studies and plasmid analysis
Transfer of mupirocin resistance from 17 isolates (Table 1) was investigated by a semi-quantitative filter mating technique. Overnight cultures of potential donor isolates and the S. aurezis recipient strain WG3358 [13] were suspended in nutrient broth. Equal volumes (100 pl) of the suspensions of each donor and the recipient were mixed on a sterile filter (0.45-pm pore Table 1 . High-level mupirocin-resistance UK hospitals size) on a nutrient agar plate and incubated overnight. Growth on the filters was harvested into 1 ml of nutrient broth and 100-pl samples were plated on to Brain Heart Infusion (BHI; Unipath) Agar containing rifampicin (Sigma) 25 mg/L and novobiocin (Sigma) 5 mg/L, together with either mupirocin (SinithKline Beecham Pharmaceuticals) 50 mg/L or gentamicin (Sigma) 4 mg/L. All donor and recipient cultures were also plated on to this selective medium as controls and incubated at 37°C for 24-48 h. Putative transconjugant colonies were subcultured on selective agar once before further non-selective passages. Plasmids were extracted from donors and transconjugants by Brij lysis [I41 or, when digestion with restriction endonucleases was required, with cetyltrimethylammonium bromide (CTAB) [13] . DNA was separated on agarose 0.8% gels at 90 V for 2-3 h in 0.5 X TBE buffer ( 1 X TBE is 89 mM Tris, 89 mM boric acid, 2 mM EDTA, pH 8) and stained with ethidium bromide (I mg/L) before being viewed under UV light. The plasmids were transferred to Hybond-N membrane (Amersham) by a VacuGene blotter (Pharmacia-LKB) and fixed at 80°C for 2 h; these blots were stored at room temperature until required for hybridisation studies.
Extraction of genomic DNA
Genomic DNA was prepared from isolates of S. azirezis with guanidium thiocyanate [ 151 and 5-pg samples were digested overnight with 10 U of Eco R1, Hinc TI or NcoI (Life Technologies). Digested DNA was electrophoresed through agarose 0.8% gels at 25 V for 16 h in 0.5 X TBE buffer and blotted to nylon membrane as above.
DNA probes for mupA and hybridisation studies
Two digoxigenin-labelled probes specific for the mupA high-level mupirocin resistance gene were used in this investigation (Fig. 1) 1987 1987 1994 1993 1994 1994 1994 1994 1990 1993 1994 1994 1994 1994 , 1994 1994 1994 
Results
Plasmids encoding mupirocin resistance
Initial studies of 15 clinical isolates and two control strains showed that the mupA resistance gene was located on plasmids of variable size in all except control strain 'STH 1' (Table 1) . For this particular strain, hybridisation always occurred with DNA that co-migrated with residual chromosomal DNA. A vague band of c. 10 MDa (possibly a plasmid) was visible at this position in some preparations from this strain. In filter mating experiments, high-level mupirocin resistance was transferred readily to 5'. aureus recipient strain WG3358 from nine of the 17 isolates, although transfer frequencies could not be determined with the semi-quantitative method used (Table 1) . Importantly, all five isolates of EMRSA-16 tested were able to act as donors in these experiments. One isolate of EMRSA-16 was also resistant to gentamicin but, while mupirocin resistance was carried on an c. 30MDa plasmid, the aminoglycoside resistance transferred separately on a plasmid of c. 40 MDa. Furthermore, mupirocin resistance transferred from this isolate at c. 1 00-fold greater efficiency than gentamicin resistance (data not shown).
Hybridisation of genomic DNA with mupirocin resistance probes
Many of the 85 clinical isolates of S. aureus used in this study contained plasmids in addition to the mupirocin resistance plasmid and, as initial studies indicated that some isolates were unable to transfer mupirocin resistance in vitro (Table l) , it was not possible to overcome this problem by generating transconjugants that contained single plasmids. Hence, direct digestion and comparison of these mupirocin resistance plasmids was not possible. In view of the large number of isolates studied, the location of the mupA gene was therefore investigated further with digests of genomic DNA, the inference being that fragments hybridising with the probe would probably be derived from the resistance plasmids rather than from chromosomal DNA.
The mzipA resistance gene was located on seven different sized EcoRI fragments of genomic DNA among the 85 isolates studied. These were designated A-G in order of increasing size ( Despite the heterogeneous EcoR I hybridisation patterns, all isolates of all groups had a 1.6-kb NcoI fragment that hybridised with probe A (Fig. 2a) ; this was consistent with predictions made from sequence data [5] . However, heterogeneity was again observed when Hinc 11-digested DNA was hybridised with probe B (Fig. 2b) . This probe was designed to investigate variation in the flanking DNA sequences proximal to mupA and was predicted to hybridise with an 863-bp HincII fragment that extended beyond the 5' end of the resistance gene (Fig. 1) . However, the actual sizes observed for the Hinc I1 fragments hybridising with probe B varied from c. 850 bp to > l o kb (Fig. 2b) . Bands of c. 850 bp were assumed to correspond to the predicted 863-bp fragment and were obtained from isolates of EcoRI groups A, B and E. Although good correlation was observed between the hybridisation patterns obtained with Hinc 11-and EcoR I-digested DNA for isolates of groups A (4.1-kb EcoRl fragment) and D (7-kb EcoRI fragment), the isolates of other EcoRI groups showed greater diversity in their Hinc I1 hybridisation patterns.
Variable location of the mupA gene within a strain
This heterogeneity of EcoR I and Hinc I1 hybridisation patterns was even observed among epidemiologically unrelated isolates of the same strain (as confirmed by phage typing and pulsed-field gel electrophoresis, data not shown). Two isolates of EMRSA-3 and six isolates of a mecA-negative IMRSA strain had two and four EcoR I hybridisation patterns, respectively (Table 1) . Twenty-one isolates of EMRSA-16 had six EcoRI hybridisation patterns (Table 1 and Fig. 3 ) and, in 16 isolates studied further, this heterogeneity correlated with variations in the digestion pattern of the mupirocin resistance plasmids (Fig. 3) .
Preliminary analysis of proximal IS25 7-mupA spacer regions
The mupA gene is flanked by direct repeats of IS257 in diverse isolates of S. aureus [7, 20] . Hybridisation studies with HincII digests and probe B suggested that the variable location of mupA might result from alterations in the flanking DNA proximal to the resistance gene. To explore this possibility further, the study attempted to amplify the spacer region between the closest proximal copy of IS257 and mupA from isolates chosen to represent each of the seven EcoRI hybridisation patterns. Three of these isolates, belonging to hybridisation groups A, E and G, yielded amplicons of variable size with primers IS2.57~ and mupAR (Table 2 ). However, variably sized amplicons were obtained from isolates representing groups C, D and F, when primer I S 2 5 7~ was used with mupAp,. Confirmation that these amplicons were indeed spacer regions was checked by hybridisation with both probe B (for mupA) and the IS257 internal probe. No spacer region was amplified with either pair of primers from the tested isolate of pattern group B. Only the c. 2-kb I S 2 5 7~-m u p A~ amplicons from isolates of groups A and E contained internal EcoRI target sites; both yielded two products of c. 1200 bp and 800 bp.
Discussion
In the present study a small panel of clinical isolates were chosen to represent strains causing current problems in UK hospitals to confirm previous reports [9-1 1, 191 that high-level mupirocin resistance (MIC 2 512 mg/L) in S. aureus is usually encoded on plasmids that vary both in size and in their ability to transfer on filters to suitable recipient strains. Therefore, it must be inferred that this resistance may also be transferable in vivo to other strains of S. aureus. The present study was unable to detect a mupirocin resistance plasmid in control strain 'STH l', as probes appeared to hybridise with residual chromosomal DNA. This strain has been shown previously to contain an atypical resistance plasmid that co-migrates with chromosomal DNA, but which may be separated by pulsed-field gel electrophoresis [9] .
In the 85 isolates studied, the mupA gene was located on seven different EcoR I fragments of genomic DNA, although in most isolates (54%) it was on a 7-kb fragment. This finding contrasts with all previous large-scale studies of S. aureus or coagulase-negative staphylococci [9-1 11 in which mupA was located on a 4.1-kb EcoRI fragment in all except two isolates examined; a similar sized fragment was the second most common among the isolates in the present study. Despite the use of digested genomic DNA for hybridisation studies, it was assumed that the DNA fragments carrying mupA were derived from mupirocin resistance plasmids, although the possibility that In the present study, the heterogeneous location of mupA was also indicated by HincII-digested DNA, although a conserved NcoI fragment was present in all isolates. As the two NcoI target sites are intragenic (Fig. l) , these data suggest that mupA itself may be conserved. However, as the EcoRI and HincII fragments predicted to hybridise with the probes extend beyond the nzupA open reading frame, it seemed probable that the variation might result from alterations in the flanking DNA proximal to the resistance gene. Although the heterogeneity might have resulted from mutations affecting EcoR I and HikcII target sites, mupA has been shown to be flanked by direct repeats of IS257 (which has no internal EcoR I or Hinc I1 target sites) and recombination [7, 191 or transposition [20] events involving these elements could also account for the differences. By amplifying the spacer regions, this study has shown that the copy of IS257 proximal to mupA can be present in either orientation and that the sizes of these spacer regions (with IS257 in either orientation) vary; a further indication of proximal heterogeneity. On the basis of these observations it is suggested that IS257-mediated events are responsible, at least in part, for the variable location of mupA in S. aureus. The molecular basis for the heterogeneity observed requires further detailed characterisation and studies are under way to sequence the flanking DNA proximal to mupA in selected isolates. Further hybridisation studies with new probes, amplification of mupA-IS257 spacer regions and sequencing are also necessary to determine whether these isolates show similar heterogeneity in the flanking DNA distal to mupA.
It is tempting to speculate that the variable location of mupA in epidemiologically unrelated isolates of certain strains of S. aureus might warrant evaluation as an epidemiological tool. Although high-level mupirocin resistance is present in diverse strains of S. aureus, its emergence in EMRSA-16 has caused particular problems. This epidemic strain is currently causing major infection control problems in many UK hospitals [3] . High-level mupirocin resistance was readily transferable in vitro from each of five EMRSA-16 isolates used in mating experiments in this study, which suggests that it will become far more widely disseminated in the future, mediated both by the spread of resistant EMRSA-16 and also by the horizontal transmission of resistance to other staphylococci, including MRSA. mupA was found on six different DNA fragments in isolates of EMRSA-16, and these differences correlated with variations in the digestion pattern of the mupirocin resistance plasmids. Hence, although the low numbers of EMRSA-16 isolates in this study did not permit correlation between fragment size and geographical area, this heterogeneity could potentially be used to monitor the dissemination of high-level mupirocin resistance within EMRSA-16 and other strains of S. aureus.
